BackFidelity Select Portfolios - Medical Technology and Devices Portfolio Overview

Fidelity Select Portfolios - Medical Technology and Devices Portfolio Current Cash

Track Fidelity Select Portfolios - Medical Technology and Devices Portfolio's current cash ($200K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$196559.00
67.66% YoYΔ $-411150.00 vs prior year quarter

Peer average

Loading

Fidelity Select Portfolios - Medical Technology and Devices Portfolio Current Cash History

Loading

Fidelity Select Portfolios - Medical Technology and Devices Portfolio vs. peers: Current Cash Comparison

Loading

Fidelity Select Portfolios - Medical Technology and Devices Portfolio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) FAQ

Fidelity Select Portfolios - Medical Technology and Devices Portfolio's current cash stands at $200K as of September 2023. That compares with $610K in the prior-year period — down 67.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Fidelity Select Portfolios - Medical Technology and Devices Portfolio reported $200K in current cash versus $610K a year earlier — a 67.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $610K in the prior-year period — down 67.7% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Fidelity Select Portfolios - Medical Technology and Devices Portfolio's current cash evolved across reporting periods, while the comparison chart places FSMEX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.